Login
$JNJ
$268.39 +$2.09 (0.78%) Live

$JNJ 5 SEC Filings

Filed On Filing
28 Jan 2026 Form 5: Johnson Paula A, Director

Returned 11 shares to the issuer

28 Feb 2025 Form 5: Woods Eugene A., Director

Bought 100 shares ($14.6K)

16 Jan 2020 Form 5: Mulcahy Anne M, Director

Received 270 shares by will or inheritance · Received 358 shares by will or inheritance

12 Feb 2016 Form 5: Johnson & Johnson, 10% owner and 1 other · Minerva Neurosciences, Inc

Bought 607,903 shares ($3M)

12 Feb 2016 Form 5: Johnson & Johnson, 10% owner and 1 other · NEVRO CORP

Sold 1,010,265 shares ($48.5M)

24 Jan 2012 Form 5: Johnson & Johnson, 10% owner and 1 other · UNIVERSAL BIOSENSORS INC

Sold 25,000 shares ($35.3K) · Sold 25,000 shares ($35.5K) · Sold 25,000 shares ($35K) · 14 more

24 Jan 2012 Form 5: Johnson & Johnson, 10% owner and 1 other · UNIVERSAL BIOSENSORS INC

Sold 50,000 shares ($74.5K) · Sold 50,000 shares ($75K) · Sold 50,000 shares ($74K) · 26 more

10 Feb 2011 Form 5: Johnson & Johnson, 10% owner and 1 other · UNIVERSAL BIOSENSORS INC

Sold 1,222 shares ($1.66K) · Sold 7,240 shares ($9.63K) · Sold 344 shares ($461) · 4 more

13 Feb 2008 Form 5: Scodari Joseph C, Executive Committee Member

Acquired 162 shares (Other Transaction)

26 Jan 2005 Form 5: Langbo Arnold G, Director

Sold 50 shares ($2.89K) · Sold 144 shares ($7.65K)

17 Feb 2004 Form 5: Johnson & Johnson, 10% owner · PROTEIN POLYMER TECHNOLOGIES INC

Acquired 10,000 Series I Preferred Stock (Open Market Purchase) ($1M) · Acquired 272,727 Series I First Common Stock Warrants (Right to Buy) (Open Market Purchase) · Acquired 181,818 Series I Second Common Stock Warrants (Right to Buy) (Open Market Purchase)

11 Feb 2004 Form 5: Perkins Brian D, Executive Committee Member

Sold 3,500 shares ($180K) · Received 13,900 shares by exercise or conversion ($386K) · Gave up 7,390 shares to cover exercise price or tax ($386K) · 1 more

27 Mar 2002 Form 5

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support